nimesulide has been researched along with Oligohydramnios in 4 studies
nimesulide: structure
nimesulide : An aromatic ether having phenyl and 2-methylsulfonamido-5-nitrophenyl as the two aryl groups.
Oligohydramnios: A condition of abnormally low AMNIOTIC FLUID volume. Principal causes include malformations of fetal URINARY TRACT; FETAL GROWTH RETARDATION; GESTATIONAL HYPERTENSION; nicotine poisoning; and PROLONGED PREGNANCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this report, we describe the case of a pregnant woman who developed oligohydramnios after taking nimesulide for neuropathic pain." | 7.83 | Lack of pharmacist-physician communication associated with nimesulide-induced oligohydramnios during pregnancy. ( Grincevičienė, Š; Grincevičius, J; Volochovič, J, 2016) |
| " This case report shows a pregnancy with anhydramnios and maternal thrombocytopenia, as side effects of the nimesulide therapy." | 7.72 | Anhydramnios and maternal thrombocytopenia after prolonged use of nimesulide. ( Bracciante, R; Manganelli, F; Paternoster, DM; Snijders, D; Torrisi, A, 2003) |
| "Nimesulide was prescribed for postoperative preterm labor prophylaxis." | 5.31 | Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide. ( Holmes, RP; Stone, PR, 2000) |
| " This case report shows a pregnancy with anhydramnios and maternal thrombocytopenia, as side effects of the nimesulide therapy." | 3.72 | Anhydramnios and maternal thrombocytopenia after prolonged use of nimesulide. ( Bracciante, R; Manganelli, F; Paternoster, DM; Snijders, D; Torrisi, A, 2003) |
| "Nimesulide was prescribed for postoperative preterm labor prophylaxis." | 1.31 | Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide. ( Holmes, RP; Stone, PR, 2000) |
| "Nimesulide therapy was continued for eight days (5-16) and was associated with a prolongation of pregnancy of 27 days (6-69)." | 1.31 | Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin? ( Bellini, P; Ghidini, A; Locatelli, A; Strobelt, N; Vergani, P, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grincevičienė, Š | 1 |
| Volochovič, J | 1 |
| Grincevičius, J | 1 |
| Paternoster, DM | 1 |
| Snijders, D | 1 |
| Manganelli, F | 1 |
| Torrisi, A | 1 |
| Bracciante, R | 1 |
| Holmes, RP | 1 |
| Stone, PR | 1 |
| Locatelli, A | 1 |
| Vergani, P | 1 |
| Bellini, P | 1 |
| Strobelt, N | 1 |
| Ghidini, A | 1 |
4 other studies available for nimesulide and Oligohydramnios
| Article | Year |
|---|---|
Lack of pharmacist-physician communication associated with nimesulide-induced oligohydramnios during pregnancy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Communication; Female; Humans; Interprofessional Rel | 2016 |
Anhydramnios and maternal thrombocytopenia after prolonged use of nimesulide.
Topics: Adult; Cyclooxygenase Inhibitors; Female; Gestational Age; Humans; Obstetric Labor, Premature; Oligo | 2003 |
Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide.
Topics: Adult; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Humans; Iso | 2000 |
Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin?
Topics: Administration, Oral; Adult; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitor | 2001 |